Completed OBSERVATIONAL NCT01272076

Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE)

Sponsor: Carl Zeiss Meditec, Inc.

Conditions Age Related Macular Degeneration Geographic Atrophy

Updated 9 times since 2017 Last updated: Dec 17, 2013 Started: Jan 31, 2011 Primary completion: Feb 28, 2011 Completion: Feb 28, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Age Related Macular Degeneration and Geographic Atrophy, this trial is completed. The trial is conducted by Carl Zeiss Meditec, Inc. and has accumulated 9 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed
Dec 2022 — Jan 2023 [monthly]

Completed
Dec 2021 — Dec 2022 [monthly]

Completed

▶ Show 4 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Carl Zeiss Meditec, Inc.

Data source: Carl Zeiss Meditec, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jackson, United States
• Oakland, United States